Head and neck squamous cell carcinoma (HNSCC) is a devastating cancer type with poor outcomes particularly when diagnosed at advanced, invasive stages. Targetable There is a significant need to improve our understanding of genetic pathways and molecular mechanisms driving advanced tumor phenotypes, in order to develop tailored therapies. Here we sought to investigate the phenotypic and molecular consequences of FA pathway loss in HNSCC cells.
Introduction
In the general population, HNSCC is associated with smoking, alcohol consumption and HPV infection, and represents the sixth leading type of cancer worldwide, with an annual incidence of 500,000. More than half of sporadic HNSCCs are diagnosed at locally advanced or metastatic stages, and approximately 50% of treated patients relapse with local or distant metastasis, both bearing poor rates of remission (1, 2) . Unfortunately, decades of research have not improved HNSCC outcomes significantly, and the classic therapeutic option, a combination of surgery, radiation and chemotherapy, leaves patients permanently disfigured. Thus, there is a need to been noted in dysplastic HN tissue and HNSCC (4, 5) . This suggests that loss of FA pathway function can provide a selective advantage to HNSCC cells. However, the underlying biological mechanisms -aside from genome instability -remain poorly understood.
Major advances in understanding how defective DNA repair pathways contribute to tumorigenesis have been achieved by studying DNA repair deficiency syndromes that often manifest during the first years of life (6) . Fanconi anemia (FA) is a rare inherited disorder where every cell of an affected individual is exquisitely sensitive to DNA cross-linking agents including mitomycin C or cisplatin (for reviews on mechanisms and disease manifestations see (7, 8) , and references within). Clinically, patients with FA are characterized by frequent congenital abnormalities, early progressive bone marrow failure, and a high propensity for developing malignancies, especially acute myeloid leukemia, and squamous cell carcinoma of the head and neck, esophageal and anogenital regions. In fact, FA patients with HNSCCs are usually diagnosed at a young age with advanced tumor stages that have a poor prognosis (9, 10) . FA has been associated with recessive mutations in one of 19 FA genes (11) , which play a crucial role in triggering and coordinating fundamental mechanisms of DNA repair for the maintenance of genome instability. When intact, the FA core complex, composed of the protein products of eight FA genes including FANCA, is assembled at the site of DNA damage and triggers monoubiquitination of the central and evolutionarily conserved pathway members FANCD2 and (12, 13) , thus triggering inappropriate DNA repair.
Individuals with heterozygous loss-of-function germ-line mutations in DNA repair genes also are at an increased risk for tumors, due to the loss of the wild-type allele in the malignant cells (6) .
Here, heterozygous germ-line defects in the 'late' genes of the FA pathway (FANCD1/J/N/O/Q/S) are predominantly associated with the development of hereditary breast/ovarian and pancreatic cancer (14, 15) . Furthermore, even sporadic tumors in patients with no family history of cancer frequently harbor mutations in DNA repair genes (3, (16) (17) (18) .
Several lines of evidence suggest that FA pathway loss in the epidermis, in contrast to the hematopoietic system, promotes growth in the basal stem and progenitor cell compartment.
First, in murine models, genetic loss of Fancd2 cooperated with transgenic HPV16 E7 expression targeted to basal epithelial cells to promote the development of HNSCC (19) .
Importantly, Fancd2 loss alone was already sufficient for a subtle yet consistent increase in basal cell proliferation in E7-negative control mice, thus highlighting a pro-proliferative role for FA pathway defects in the normal epidermis and in an HPV negative environment. Second, using HPV immortalized human keratinocytes, we have previously reported that FANCA or FANCD2 knockdown drive proliferation and HPV E7-dependent hyperplasia in 3D organotypic epithelial raft but not in 2D keratinocyte culture systems (20) . Third, we have recently reported that defects in the FA pathway stimulate HPV genome amplification and accumulation of the HPV E7 oncoprotein with concomitant cellular proliferation (21, 22) . Forth, FA patient-derived HNSCC cell lines were shown to harbor either similar or increased stem cell populations when compared to sporadic HNSCC lines, using tumor sphere formation, CD44 positivity or ALDH1 status as experimental end points (23, 24) .
In order to define the functional effects of acquired FA deficiency in HNSCC cells, we generated isogenic FA HNSCC models using shRNA-mediated stable knockdown and rescue strategies in HPV positive and negative tumor cell lines. While depletion of the key FA pathway components FANCA, FANCD2 and FANCJ induced classical FA phenotypes in these cells when exposed to DNA crosslinkers, minor to no effects on tumor cell growth were observed under standard 
Materials and Methods
Cell culture. The UM-SCC1, UM-SCC6, and UM-SCC47 cell lines were derived and maintained as previously described (25) . All cell lines were authenticated regularly by their morphologic characteristics and analysis of corresponding genetic and molecular markers. Nontargeting, and the results were analyzed using FlowJo (Treestar).
RNA Sequencing. Individual samples were aligned to the Hg19 genome using TopHat v1.4.1. Gene quantification was performed with Cufflinks v2.0.0 with the "-G -u -b" parameters and the Ensembl gene model. Gene-level quantifications were used throughout. Data was analyzed with GeneSpring 12.6.1 NGS, filtering to remove duplicates, and filtering on post alignment read metrics to remove reads with mapping quality below 40, or with more than one match to genome, or failing vendor QC. Quantification was carried out with DESeq as normalization algorithm and threshold normalized counts to 1, baseline to median of all samples. We filtered to remove genes with fewer than 3 RPKM in at least one sample.
Differential expression was determined with the Audic Claverie test (P < 0.05, FC > 1.5).
Functional enrichment analysis was carried out with ToppGene and cytoscape figures were made using ToppCluster.
Western blot analysis. Whole-cell protein extracts were harvested and lysed using 1X Laemmli buffer. Blotting was performed as previously described (21 Three-dimensional epithelial raft cultures. Organotypic rafts were generated as described previously (20) . Briefly, a total of 1x10 6 UM-SCC1 cells were plated on a collagen matrix with embedded feeder fibroblasts. Exposure to the liquid-air interface resulted in the generation of stratified epithelium with differentiation properties that reflect its natural human counterpart. The tissue was fixed in 2% paraformaldehyde after 16 days of growth, embedded in paraffin, sectioned and morphologically examined by hematoxylin-and-eosin staining.
Immunofluorescence and DIC Imaging. Immunofluorescence was performed as previously described (20) performed. Graphs were generated using GraphPad Prism 6 and a paired student t-test was applied to determine significance.
Chicken Chorioallantoic Membrane (CAM) assays. Fertilized White Leghorn chicken eggs
were incubated while rotating at 37°C in a humidified atmosphere (>60% relative humidity).
After 48 hours, 0.5mL of albumin was removed from each egg and the eggs were placed into a non-rotating incubation chamber at 37°C in a humidified atmosphere. After 48 hours, the eggs were windowed to expose the CAM, vasculature and viable embryo. To evaluate tumor cell invasion, a thinly sliced pipette ring was placed on top of the chorion layer of the membrane and a 25uL suspension of 500,000 UM-SCC1 cells that were either FA-deficient or -proficient and embedded in matrigel were pipetted into the ring onto the membrane. Egg shell windows were covered with scotch tape and the eggs were returned to the non-rotating incubator. Following an additional 72 hours of incubation, CAMs with tumor cells were harvested, fixed in 4%
Research. paraformaldehyde, processed, embedded in paraffin blocks, and sectioned. 5 micron sections were utilized for standard hematoxylin and eosin staining.
Rac1 activity assay. The Active Rac1 Pull-Down and Detection Kit (Thermo Scientific, Waltham, MA) was used to detect active Rac1 in the absence and presence of DNA-PKcs inhibitor NU7026 (Tocris Bioscience, Bristol, UK). Briefly, cells were plated at equal cell number and allowed to adhere. Cells were treated with either vehicle or 10 μM NU7026 for 24 h. Prior to harvesting, cells were exposed to a 30 min pulse of bleomycin (10 μg/ml). Cells were harvested and lysed as directed by the kit and protein concentrations were determined using the Pierce BCA Protein Assay Kit according to manufacturing instructions (Thermo Scientific, Waltham, MA). Equivalent amounts of protein were loaded onto the column and the protocol outlined within the assay kit was followed. Following elution of activated Rac1 from the column, western blot analysis for Rac1-GTP was performed using the anti-Rac1 mouse monoclonal antibody (1:1000) provided in the assay kit. GTPγS (positive control) and GDP (negative control) were used as controls in the pull-down assays.
Statistics. Statistical significance was determined using two-way analysis of variance (ANOVA)
with Sidak post hoc tests using an α value of 0.05 for all calculations using phalloidin projection data. All other significance was determined using a Student t-test. Statistical analyses were performed using GraphPad Prism 6 software. We have recently analyzed whole exome sequencing data of therapy-naïve HNSCCs (26) and found that a significant proportion of sporadic HNSCCs harbor somatic mutations in FA and FArelated genes (3) . In order to confirm this with sequencing data from other patient cohorts, we queried The Cancer Genome Atlas (TCGA) (27) (n=306), as well as whole sequencing data from a set of 34 primary human HNSCCs. 11.1% and 17.6%, respectively, of such tumors (Fig. 1c) . (Fig. 1d) . FANCD2 and FANCJ loss did not increase the proliferation of UM-SCC1 cells, but either decreased or did not change proliferation (Fig. 4d, S1b) . In HPV16 E7
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expressing UM-SCC1 cells, FANCD2 loss did not affect cellular proliferation (Fig. S1c) . Similar decreases or no effects were observed in UM-SCC6 and UM-SCC47 cell lines (data not shown).
Taken together, FA knockdown in HNSCC cell lines did not alter and sometimes reduced cellular growth under standard 2D culture conditions, and conferred classical FA phenotypes in the presence of DNA crosslinkers.
FA loss deregulates epithelial HNSCC morphology and cytoskeletal organization.
To assess global expression patterns induced by perturbing the FA pathway, we performed RNA sequencing (RNASeq) of the above HPV16 E7 positive UM-SCC1 cells, either depleted for FANCD2 or control transduced (Fig. 1b) . A number of genes were differentially expressed in the FANCD2sh compared to the NTsh HNSCC cells (Supplemental Table 1 ). Following identification of genes with significantly altered expression, ToppGene was used to perform gene ontology analysis and redundancies were eliminated. A large number of gene ontology hits were identified (Supplemental Table 2 ). Tables 1 and 2 ). Importantly, this was not accompanied by the induction of proliferative gene signatures, in agreement with a lack of proliferative gains in the above FA HNSCC cell populations under standard conditions and with previously published data using patient-derived cell lines (Fig. 1d and data not shown) (20) .
Among the top biological processes were cellular motility and invasion. Increased expression of the intermediate filament vimentin was noted which has already been linked to a number of cancers as a mesenchymal marker for invasive potential (30) . Vimentin induction in FA HNSCC cells was validated by qRT-PCR (Fig. 2b) . In contrast, the expression of other genes involved in classical epithelial-to-mesenchymal transition (EMT), such as E-cadherin, snail1, or twist1 was not altered. Perhaps related to the observed regulation of genes involved in cellular motility, we observed a marked alteration in the expression of genes involved in cellular adhesion and locomotion (Fig. 2a) . Further morphological examination of FA depleted UM-SCC1 cells by differential interference contrast (DIC) microscopy revealed a clear difference in cellular shape and spatial arrangement. FANCD2 and FANCJ knockdown in the UM-SCC1 cell line impaired SCC epithelial morphology: cells physically separated from each other but remained connected by intercellular projections that were largely absent in the control HNSCC cells (Fig. 2c) . To further investigate the intercellular projections, the F-actin marker phalloidin was used to stain (Fig.   2e) . Interestingly, while FA-deficient cells were able to grow and assemble into 3D tissue, we noted their occasional presence in the underlying collagen matrix, a feature which was not shared by the FA-proficient counterparts. We therefore tested the possibility that FA-deficient cells harbored increased invasive properties.
FA pathway loss in HNSCC cells promotes cellular invasion
Tumor cell invasiveness was determined directly using Matrigel transwell assays. Both HPV16 E7+ and E7-UM-SCC1 cells were significantly more invasive when knocked down for FANCD2 compared to empty vector controls (Figs. 3a and b) . Invasion was not an indirect consequence of increased proliferation (Fig. 1d , data not shown) or increased cellular adhesion (Fig. S2a) .
Similarly, FANCA and FANCJ knockdown also stimulated invasion in UM-SCC1 cells (Fig. 3c) .
To rule out any off target effects for the lentiviral knockdown approach, we next expressed a shRNA-resistant FANCD2 construct in FANCD2sh UM-SCC1 cells (Fig. 3d) . As predicted, the introduction of EGFP-FANCD2 was sufficient to rescue UM-SCC1 FANCD2 shRNA cells from invasion (Fig. 3d) . Expression of the EGFP-FANCD2 fusion protein was confirmed by western blot analysis on the right. Finally, FANCA and FANCD2 knockdown in UM-SCC6 and UM-SCC47 cells also stimulated tumor cell invasion (Figs. 3e and f) . As expected, the increased invasiveness of the cancer cells correlated with increased motility seen by standard migration assays (Fig. S2b) . In order to further assess the invasive properties of FA-deficient versusproficient tumor cells, we utilized chicken chorioallantoic membrane (CAM) assays (Fig. S3) .
Interestingly, FA-deficient cells were occasionally able to invade into the chorion membranes of living chick embryos, and more specifically appeared to invade as cell clusters; however, invasion was never observed with their FA-proficient counterparts. Taken together, FA loss leads to a dramatic increase of invasive capacity and motility in HPV positive and negative HNSCC cells. FA cells exhibit characteristic sensitivity to DNA crosslinkers, and defects in error-free DNA repair by homologous recombination (HR). These defects are accompanied, under some circumstances, by a corresponding increase in the activity of error-prone non-homologous end joining (NHEJ) pathway components (12, 13) . NHEJ requires the activation of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and subsequent autophosphorylation on serine 2056 (31) . In order to probe a possible functional involvement for DNA-PKcs signaling in FA-associated invasion, we first determined whether FANCD2-and FANCJ-deficient UM-SCC1 cells harbored activated DNA-PKcs. We then verified the functionality of a DNA-PK inhibitor NU7026 in this system in order to probe the importance of DNA-PK activity for invasion (Fig. 4a) .
Invasion in response to
Control cells and their FANCD2 and FANCJ-depleted counterparts were subjected to a pulse of bleomycin in order to stimulate DNA damage signaling, and the cells were then treated with vehicle or with the DNA-PKcs inhibitor NU7026. Cells were analyzed for activated DNA-PKcs phosphorylated on serine 2056. FANCD2 and particularly FANCJ loss stimulated DNA-PKcs phosphorylation compared to control (Fig. 4a, lanes 1-3) , and autophosphorylation was completely eliminated by NU7026. Next, we determined whether DNA-PKcs activation was functionally important for FA-deficient cancer cell invasion. DNA-PKcs inhibition by NU7026 suppressed the invasive phenotype in FANCD2sh UM-SCC1 cells (Fig. 4b) , but did not impair cellular viability (Fig. 4c) . Importantly, DNA-PKcs inhibition also reduced control cell invasion under these conditions, thus indicating that DNA-PK activation contributes to HNSCC cell invasion. The ability of NU7026 to suppress invasion in FA-deficient cells was also observed in HPV+ FANCD2sh (Fig. S4a) and FANCAsh (Fig. S4b) UM-SCC47 cells.
Invasion in response to FA loss requires Rac1 GTPase activity.
Ras-related small GTPase Rho/Rac/CDC42 signaling pathways are key players in cellular morphology and invasion (32) . Because the activation of Rac1 was reported to produce intercellular projections similar to the ones noted for FA-deficient cells (Fig. 2) (33, 34) , we carried out Rac1-GTP pull downs to first determine whether Rac1 is activated in FA HNSCC cells, and if so, to probe a possible role for DNA-PKcs in its regulation. FANCJsh knockdown cells were chosen based on the observation that DNA-PK activation was maximal in FANCJ when compared to FANCD2 knockdown cells in Fig. 4a . Interestingly, FANCJsh transduced UM-SCC1 cells showed increased Rac1 activity when compared with their NTsh control transduced counterparts (Fig. 5a, compare lanes 1 and 3) . Treatment with DNA-PKcs inhibitor did not affect Rac1 activity in the control NTsh cells (Fig. 5a, compare lanes 1 and 2) , but significantly lowered Rac1 activity in FANCD2sh and FANCJsh cells (Fig. 5a, compare lanes 3 Research.
on April 14, 2017. © 2015 American Association for Cancer clincancerres.aacrjournals.org Downloaded from and 4). Taken together, these results suggest that Rac1 activation downstream from FA loss is, at least in part, dependent upon DNA-PKcs activity. We next sought to examine the requirement for Rac1 GTPase activity in the characteristic cytoskeletal reorganization and invasion of FAdeficient HNSCC cells. We utilized NSC23766, a small molecule that has been shown to specifically inhibit Rac1 structural and functional activity but does not affect the activity of other Rho-related small GTPases (35, 36) . Interestingly, NSC23766 reduced the number of intercellular protrusions and stimulated cell-cell adhesion in FANCD2-and FANCJ-deficient compared to control UMSCC1 cells as assessed by DIC (Fig. 5b, top panel) and phalloidin staining (Fig. 5b, bottom panel and quantification below) . To determine whether NSC23766 was also capable of suppressing cellular invasion in response to FANCD2 loss, FA-proficient anddeficient HNSCC cells were treated with NSC23766 or vehicle over the course of the transwell assay. Indeed, cellular invasion following FANCD2 loss was repressed by NSC23766 which did not significantly affect control cell invasion (Fig. 5c ) or cellular growth (Fig. 5d ). NSC23766 could also suppress invasion in FA-deficient HPV+ UM-SCC47 cells (Fig. S4c) . Together, these data demonstrate that FA loss and subsequent DNA-PK activation promote Rac1 activity to induce cytoskeletal aberrations and invasive tumor phenotypes in HNSCC cells (see Fig. 5e sensor in advanced HNSCC for the first time. While the nuclear role of DNA-PK in DNA repair is well characterized, non-canonical activities have emerged as well. DNA-PK has been implicated in inflammation through the phosphorylation of NF-kB1 (39) , and in metabolic gene regulation through interaction with and phosphorylation of USF-1 (40) . Furthermore, a number of novel cytoplasmic DNA-PK substrates were published recently that participate in cytoskeletal regulation (41) . These include members of the 14-3-3 protein family, vimentin, and desmoplakin.
The authors showed that DNA-PK activation decreased motility in melanoma cell lines, in contrast to increased invasion in our HNSCC cells. Thus whereas advanced cancer phenotypes are regulated by DNA-PK in both systems, the direction of the observed regulation may be cell type specific. Such differences might reflect significant complexity in the regulation of cytoskeletal components by DNA-PK. Further analysis identified a novel link between DNAPKcs and Rac1 signaling in FA HNSCC cells wherein a specific DNA-PK inhibitor decreased active Rac1-GTP protein levels. One possible mechanism might be supported by a previous finding that DNA-PKcs can physically interact with the CDC42/Rac1 guanine exchange factor, ARHGEF6, in ovarian cancer cells (42) . In addition, growing evidence supports correlations between DNA damage signaling and Rac1 activity (43) (44) (45) , although the mechanisms and functional relevance of pathway cross-talk are largely unclear. Whether DNA-PKcs activates Rac1 directly through guanine nucleotide exchange factors or indirectly through signal transduction cascades is currently under investigation.
Rac1 is a well-known regulator of the cellular actin cytoskeleton, adhesion, barrier function and migration. Like other members of the Rho family, Rac1 cycles between GDP-bound inactive and GTP-bound active states (46) . These GTPases are controlled by two classes of regulatory molecules: activating guanine nucleotide exchange factors (GEFs), and repressive GTPaseactivating proteins (GAPs). Previously published work found that Rac1 was required for Krasmediated tumorigenesis in skin epithelium and the lung (47, 48) . More importantly, Rac1 activity strongly is associated with cell motility and tumor metastasis (49, 50). We found that both cell morphology (protrusion formation) and cellular invasion were dependent upon Rac1 activation, and show a reversion of the FA deficient HNSCC cell phenotype to a more epithelial-like morphology following inhibition of Rac1. We also observed a significant decrease in cancer cell 
